336 related articles for article (PubMed ID: 10388747)
21. Expression and function of the gamma c subunit of the IL-2, IL-4, and IL-7 receptors. Distinct interaction of gamma c in the IL-4 receptor.
He YW; Adkins B; Furse RK; Malek TR
J Immunol; 1995 Feb; 154(4):1596-605. PubMed ID: 7530740
[TBL] [Abstract][Full Text] [Related]
22. Analysis of the multiple interactions between IL-12 and the high affinity IL-12 receptor complex.
Presky DH; Minetti LJ; Gillessen S; Wilkinson VL; Wu CY; Gubler U; Chizzonite R; Gately MK
J Immunol; 1998 Mar; 160(5):2174-9. PubMed ID: 9498755
[TBL] [Abstract][Full Text] [Related]
23. Quantitative characterization of the intrinsic ligand-binding affinity of the interleukin 2 receptor beta chain and its modulation by the alpha chain and a second affinity-modulating element.
Ringheim GE; Freimark BD; Robb RJ
Lymphokine Cytokine Res; 1991 Jun; 10(3):219-24. PubMed ID: 1883916
[TBL] [Abstract][Full Text] [Related]
24. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
25. Comparative analysis of the kinetics of binding and internalization of IL-5 in murine IL-5 receptors of high and low affinity.
Mita S; Takaki S; Tominaga A; Takatsu K
J Immunol; 1993 Dec; 151(12):6924-32. PubMed ID: 8258700
[TBL] [Abstract][Full Text] [Related]
26. Interleukin-13 receptor alpha chain: a novel tumor-associated transmembrane protein in primary explants of human malignant gliomas.
Joshi BH; Plautz GE; Puri RK
Cancer Res; 2000 Mar; 60(5):1168-72. PubMed ID: 10728667
[TBL] [Abstract][Full Text] [Related]
27. STAT-1 is activated by IL-4 and IL-13 in multiple cell types.
Wang IM; Lin H; Goldman SJ; Kobayashi M
Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459
[TBL] [Abstract][Full Text] [Related]
28. Unexpected effects of the IL-2 receptor alpha subunit on high affinity IL-2 receptor assembly and function detected with a mutant IL-2 analog.
Kuziel WA; Ju G; Grdina TA; Greene WC
J Immunol; 1993 Apr; 150(8 Pt 1):3357-65. PubMed ID: 8468475
[TBL] [Abstract][Full Text] [Related]
29. Differential responses of human monocytes and macrophages to IL-4 and IL-13.
Hart PH; Bonder CS; Balogh J; Dickensheets HL; Donnelly RP; Finlay-Jones JJ
J Leukoc Biol; 1999 Oct; 66(4):575-8. PubMed ID: 10534111
[TBL] [Abstract][Full Text] [Related]
30. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor.
Feng N; Schnyder B; Vonderschmitt DJ; Ryffel B; Lutz RA
J Recept Signal Transduct Res; 1995; 15(7-8):931-49. PubMed ID: 8673724
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-13 receptor alpha2 chain in human head and neck cancer serves as a unique diagnostic marker.
Kawakami M; Kawakami K; Kasperbauer JL; Hinkley LL; Tsukuda M; Strome SE; Puri RK
Clin Cancer Res; 2003 Dec; 9(17):6381-8. PubMed ID: 14695138
[TBL] [Abstract][Full Text] [Related]
32. Two distinct affinity binding sites for IL-1 on human cell lines.
Bensimon C; Wakasugi N; Tagaya Y; Takakura K; Yodoi J; Tursz T; Wakasugi H
J Immunol; 1989 Aug; 143(4):1168-74. PubMed ID: 2526182
[TBL] [Abstract][Full Text] [Related]
33. Subunit structure of the high and low affinity human interleukin-15 receptors.
Lehours P; Raher S; Dubois S; Guo J; Godard A; Jacques Y
Eur Cytokine Netw; 2000 Jun; 11(2):207-15. PubMed ID: 10903799
[TBL] [Abstract][Full Text] [Related]
34. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
Kawakami K; Leland P; Puri RK
Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
[TBL] [Abstract][Full Text] [Related]
35. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
36. Analysis of antitumor activity of an interleukin-13 (IL-13) receptor-targeted cytotoxin composed of IL-13 antagonist and Pseudomonas exotoxin.
Kioi M; Kawakami K; Puri RK
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6231-8. PubMed ID: 15448012
[TBL] [Abstract][Full Text] [Related]
37. Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and nonhemopoietic cells.
Lowenthal JW; Castle BE; Christiansen J; Schreurs J; Rennick D; Arai N; Hoy P; Takebe Y; Howard M
J Immunol; 1988 Jan; 140(2):456-64. PubMed ID: 2961813
[TBL] [Abstract][Full Text] [Related]
38. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
[TBL] [Abstract][Full Text] [Related]
39. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
Kawakami K; Kawakami M; Husain SR; Puri RK
Gene Ther; 2003 Jul; 10(13):1116-28. PubMed ID: 12808442
[TBL] [Abstract][Full Text] [Related]
40. Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor alpha1 chain.
Knackmuss S; Krause S; Engel K; Reusch U; Virchow JC; Mueller T; Kraich M; Little M; Luttmann W; Friedrich K
Biol Chem; 2007 Mar; 388(3):325-30. PubMed ID: 17338640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
